GeoWealth Management LLC Has $682,000 Stock Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

GeoWealth Management LLC cut its holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 18.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,246 shares of the company’s stock after selling 2,320 shares during the period. GeoWealth Management LLC owned approximately 0.25% of Invesco Biotechnology & Genome ETF worth $682,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in shares of Invesco Biotechnology & Genome ETF during the 4th quarter worth approximately $1,256,000. Jane Street Group LLC acquired a new position in Invesco Biotechnology & Genome ETF in the 3rd quarter valued at $295,000. Commonwealth Equity Services LLC lifted its position in shares of Invesco Biotechnology & Genome ETF by 16.9% during the 4th quarter. Commonwealth Equity Services LLC now owns 26,002 shares of the company’s stock valued at $1,730,000 after acquiring an additional 3,764 shares during the period. Farther Finance Advisors LLC acquired a new stake in shares of Invesco Biotechnology & Genome ETF during the 4th quarter worth $161,000. Finally, LPL Financial LLC increased its position in shares of Invesco Biotechnology & Genome ETF by 1.7% in the fourth quarter. LPL Financial LLC now owns 92,105 shares of the company’s stock worth $6,128,000 after purchasing an additional 1,503 shares during the period.

Invesco Biotechnology & Genome ETF Stock Down 0.0 %

PBE opened at $59.03 on Monday. Invesco Biotechnology & Genome ETF has a twelve month low of $54.52 and a twelve month high of $72.84. The stock has a market capitalization of $212.51 million, a price-to-earnings ratio of 21.05 and a beta of 0.83. The company has a 50-day simple moving average of $64.03 and a 200 day simple moving average of $67.12.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.